Use the Search Fields to Find Information
Page 112 of 373
Nonmedical versus medical marijuana use among three age groups of adults: Associations with mental and physical health status
Please use this link to access this publication. Abstract Background and Objective Given that 29 U.S. states now have laws allowing medical marijuana use, this
August 5, 2024
Nonmedical Cannabis Use: Patterns and Correlates of Use, Exposure, and Harm, and Cancer Risk
Abstract Cannabis has certain health benefits, but some people may experience harms from use. Co-use of tobacco and cannabis is common. Smoke from cannabis contains
July 20, 2025
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms
BACKGROUND AND PURPOSE Cannabinoid receptor activation induces prostate carcinoma cell (PCC) apoptosis, but cannabinoids other than D9 -tetrahydrocannabinol (THC), which lack potency at cannabinoid receptors,
September 19, 2019
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Abstract Delta(9)-tetrahydrocannabinol binds cannabinoid (CB(1) and CB(2)) receptors, which are activated by endogenous compounds (endocannabinoids) and are involved in a wide range of physiopathological processes
Non-psychotropic Cannabis sativa L. phytocomplex modulates microglial inflammatory response through CB2 receptors-, endocannabinoids-, and NF-κB-mediated signaling
Abstract Cannabis sativa L. is increasingly emerging for its protective role in modulating neuroinflammation, a complex process orchestrated among others by microglia, the resident immune cells
February 8, 2024
Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation
Cannabinoids, the active components of marijuana and their endogenous counterparts, act on the brain and many other organs through the widely expressed CB1 cannabinoid receptor.
September 19, 2019
Non-Intoxicating Cannabinoids in Visceral Pain
Please use this link to access this publication: https://www.liebertpub.com/doi/abs/10.1089/can.2023.0113 Abstract Cannabis and cannabis products are becoming increasingly popular options for symptom management of inflammatory bowel diseases,
December 6, 2023
Non-Cannabinoid Metabolites of Cannabis sativa L. with Therapeutic Potential
Abstract The cannabis plant (Cannabis sativa L.) produces an estimated 545 chemical compounds of different biogenetic classes. In addition to economic value, many of these
March 28, 2024
Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study
Please use this link to access this publication. Abstract The possible medicinal use of cannabinoids for chronic diseases emphasizes the need to understand the long-term
November 4, 2024
Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study
The possible medicinal use of cannabinoids for chronic diseases emphasizes the need to understand the long-term effects of these compounds on the central nervous system.
September 19, 2019
Page 112 of 373